HighTower Advisors LLC Sells 4,063 Shares of Amgen Inc. $AMGN

HighTower Advisors LLC reduced its stake in Amgen Inc. by 0.5% in the second quarter, selling 4,063 shares and retaining 816,257 shares valued at $295.6 million. Despite this, Amgen exceeded quarterly expectations with $6.29 adjusted EPS and $10.05 billion in revenue, showing 9.5% year-over-year growth. The company also announced a quarterly dividend of $2.52 per share and has a consensus "Hold" rating from analysts with a $381.68 price target.